Tony Zook

Tony Zook

Director and Chief Executive OfficeratNeogenomics· In proxies 2023–2025

Pay in FY2025Neogenomics stock -28.6% the same year

Tony Zook was paid $9.1M in FY2025 (Dec). Neogenomics stock fell 28.6% that year.

Pay$100 in the stock at the end of FY22 → $127
Pay is from the Summary Compensation Table of each Neogenomics proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. NeogenomicsPublic company · 3 yr
    • Director and Chief Executive Officer2023 – Present · 3 yrStock in role +98%
  2. Adaptin Bio, Inc.Public company · 1 yr
    • Director2025 – Present · 1 yrNo stock prices for these years
  3. Algorithm Sciences, Inc.Public company
    • Director? – PresentNo stock prices for these years
  4. Voltron Therapeutics, Inc.Public company · 2 yr
    • Director2022 – 2024 · 2 yrNo stock prices for these years
  5. BioSig Technologies, Inc.Public company · 2 yr
    • Director2020 – 2022 · 2 yrNo stock prices for these years

Roles come from the proxy statements of each company.

Boards1

  • NeogenomicsDirector · 0 yr on the boardIndependentAudit and Finance, Culture and Compensation (Chair), Innovation, Pipeline & Technology—Paid as an executive

Board seats come from each company's latest proxy statement.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?